Chronic kidney disease in children in Ukraine

Keywords: epidemiology, etiology, progression, outcome, pathomorphosis, polycystic kidney disease, congenital anomalies of the kidney and urinary tract, kidney dysplasia, glomerulonephritis, acute kidney injury, dialysis, kidney transplantation.

Abstract

The study aimed to summarize data of Chronic Kidney Disease (CKD) in children and adolescents in Ukraine.

Methods. There were performed a qualitative study based on published documents and registers, and a cohort observational study included 3528 depersonalized patients with CKD diagnosed before the age of 18. That was used cross-sectional and longitudinal design for the structure, etiology, and outcomes analysis, period comparison (years 2014 and 2019), quantitative analyzes depending on patients age and nosology, risk measurements and survival function.

Results. There was found the tendency to reduce the incidence of the genitourinary system diseases in childhood, and the predominance of these classes of diseases in adolescents. The main causes of CKD were congenital structural or histological abnormalities and glomerulonephritis. Prolonged kidney function preservation at the initial level was confirmed in many patients (CKD1 was maintained in 33.0% and CKD5 - in 56.6% causes after 5 years period) with the partial function improvement in CKD1-3. CKD1-4 probability at the 1st year of observation was 91.7±0.47%, at the 5th year - 84.2±0.82%. The structural CKD5 specialties in patients receiving Kidney Replacement Therapy have been established. There was a significantly higher risk of CKD5 during 5 years period after Acute Kidney Injury (OR 2.81-2.10), and a lower probability of CKD5 in patients with glomerulonephritis (OR 0.66-0.54) compared to other nosology. CKD pathomorphosis was found in the year 2019 compared to the year 2014: the kidney dysplasia as an etiological factor was increased (from 19.3% to 22.0%, р=0.040); the immediate outcome at the 1st year of observation was improved with the lower risk of declaring of Glomerular Filtration Rate (GFR) to CKD5 level (93.6% vs. 90.0%), but the late follow-up prognosis became worse (the cumulative probability of CKD1-4 at the 5th year of observation decreased from 85.5 to 73.9%, p=0.016); the structure of Kidney Replacement Therapy changed with the increasing part of transplanted patients (from 30.5% to 48.9%, p<0.001), especially as a first choice (pre-dialysis); the tendency to decrease the proportion of polycystic kidney disease in CKD and to increase it in CKD5 was revealed with risk raising of GFR loss <15 ml/min in the year 2019 compared to other nosology (OR 1.69, p=0.027).

Conclusions. The established epidemiological and clinical realities are important for determining the kidney disease outcome in children and adolescents, assessing the medical management of these patients, sharpening the priorities of pediatric nephrology, and emphasizing the significance of further studies with appropriate regulations.

Downloads

Download data is not yet available.

References

Levin A, Tonelli M, Bonventre J, Coresh J, Donner J-A, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888-1917. doi.org/10.1016/S0140-6736(17)30788-2.

Global, regional, and national burden of chronic renal disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. GBD Chronic Kidney Disease Collaboration. Lancet. 2020;395:709–33. https://doi.org/10.1016/S0140-6736(20)30045-3.

Delanaye P, Glassock RJ, De Broe ME. Epidemiology of chronic kidney disease: think (at least) twice! Clin Kidney J. 2017;10:370-374. doi: 10.1093/ckj/sfw154.

GBD 2016 Causes of Death Collaborators. Global, regional, and national age‐sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–210. doi: 10.1016/S0140-6736(17)32152-9.

Verhave JC, Troyanov S, Mongeau F, Fradette L, Bouchard J, Awadalla P, Madore F. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care. Clin J Am Soc Nephrol. 2014;9:713–9. doi: 10.2215/CJN.06550613.

Ng JK-C, Li PK-T. Chronic kidney disease epidemic: How do we deal with it? Nephrology. 2018;23(Suppl.4):116–20. doi: 10.1111/nep.13464.

Haynes RB, Sackett DL, Guyatt GH, Tugwell PS. Clinical Epidemiology: How to do Clinical Practice Research. 3rd ed. Philadelphia, PA: Lippincott Williams Wilkins; 2006. 496 р.

International Ethical Guidelines for Health-related Research Involving Humans, Fourth Edition. Geneva. Council for International Organizations of Medical Sciences (CIOMS); 2016. 119 s. Available from: https://fk.unair.ac.id/wp-content/uploads/2019/09/CIOMS-EthicalGuidelines2016.pdf.

ESPN/ERA-EDTA Registry. Paediatric Data. January 2020. Available from: https://www.espn-reg.org/files/AR2017_20200224.pdf.

ESPN/ERA-EDTA Registry. Paediatric Data 2016. November 2018. Available from: https://www.espn-reg.org/files/AR2016_final.pdf.

Demohrafichna ta sotsialna statystyka / Naselennia ta mihratsiia / Richni dani / Naselennia (1990-2019). Available from: http://www.ukrstat.gov.ua. [In Ukrainian].

Statystychnyi zbirnyk «Zaklady okhorony zdorovia ta zakhvoriuvanist naselennia Ukrainy», 2017 rik. Available from: http://www.ukrstat.gov.ua. [In Ukrainian].

Kolesnyk MO, hol. redaktor. Natsionalnyi reiestr khvorykh na khronichnu khvorobu nyrok ta patsi-ientiv z hostrym poshkodzhenniam nyrok: 2017 rik / uklad. NI Kozliuk, OО Razvazhaieva; Derzhavna ustanova «Instytut nefrolohii NAMN Ukrainy». Kyiv; 2018.183 s. [In Ukrainian].

KT Clearinghouse. Knowledge Translation Program. Toronto 2017. ESPN/ERA-EDTA Registry. Paediatric Data 2016. November 2018. Available from:  https://ebm-tools.knowledgetranslation.net/calculator.

Bagdasarova IV, Fomina SP. Chronic Kidney Disease and Renal Replasement Therapy in Ukraine. Ukrainian journal of nephrology and dialysis 2015;1(45):3-8. doi.org/10.31450/ukrjnd.1(45).2015.01 [In Ukrainian].

Tonelli M, Dickinson JA. Early detection of CKD: implications for low-income, middle-income, and high-income countries. JASN. 2020;31(9):1931-40. doi: 10.1681/ASN.2020030277.

Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in developed countries. Kidney Int Rep. 2020;5:263–77. doi: 10.1016/j.ekir.2019.12.003.

Masalskien˙e J, Rudaitis Š, Vitkevic R, Cerkauskiene R, Dobiliene D, Jankauskien A. Epidemiology of Chronic Kidney Disease in children: a report from Lithuania. Medicina. 2021;57:112-20. doi: 10.3390/medicina57020112.

Luo S, Grams ME. Epidemiology research to foster improvement in chronic kidney disease care. Kidney Int. 2020;97(3):477-86. doi: 10.1016/j.kint.2019.11.010.


Abstract views: 567
PDF Downloads: 15896
Published
2021-01-09
How to Cite
Fomina, S. P. (2021). Chronic kidney disease in children in Ukraine . Ukrainian Journal of Nephrology and Dialysis, (1(69), 16-26. https://doi.org/10.31450/ukrjnd.1(69).2021.03